 |
Group Leader | Obesity and Metabolism Lab, The University of AdelaideProfessor Leonie Heilbronn leads the Obesity and Metabolism lab at The University of Adelaide and the South Australian Health and Medical Research Institute, where she is also Deputy Director of the Nutrition, Diabetes and Gut Health Program. Her research investigates the metabolic effects of caloric restriction, fasting, meal timing, and sleep, and how these may collectively interact to prevent chronic diseases like type 2 diabetes. Prof Heilbronn has published > 140 peer-reviewed manuscripts with a H-index of 53 and >14,500 citations. She is President of the Australia and New Zealand Obesity Society (ANZOS) and an Associate Editor of Obesity and the European Journal of Endocrinology. |
Cardiometabolic Syndrome Presentation PDF Slides
ASM Symposium title: CURTAILING CALORIES OR TIME? EXPLORING THE IMPACTS OF CALORIC RESTRICTION AND MEAL TIMING ON GLUCOSE CONTROL
Weight management is good chronic disease management. Modest caloric restriction is beneficial for glucose control and prevents the development of type 2 diabetes for up to 10 years. It also has beneficial actions for other metabolic diseases, including liver disease, heart disease and chronic kidney disease. Weight losses of 5-10% have significant benefits to reduce disease progression, and 15% can put diabetes into remission. However, weight loss is biologically defended, hampering long-term success. The next generation of pharmacotherapy is approaching the successes seen with bariatric surgery. However, weight losses are reversed if the medication is ceased, and it will be important to optimise lifestyles to minimise muscle losses and micronutrient deficiency. The emerging evidence for the novel role of chrononutrition and chronotherapy in modulating disease risk will also be discussed.